Drugmaker Shionogi & Co Ltd has applied for approval to make and sell its oral COVID-19 treatment in Japan, the firm said on Friday.

Known as S-217622, the drug would become the country's third antiviral pill approved for coronavirus patients, following those developed by Pfizer Inc  and Merck & Co .

(Reporting by Rocky Swift; Editing by Clarence Fernandez)